公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2020 | Time to be familiar with nontuberculous mycobacterial lung disease - An emerging disease with diverse clinical outcomes | JANN-YUAN WANG ; JIN-YUAN SHIH ; Lin M.-C. | Journal of the Formosan Medical Association | 2 | 0 | |
2022 | Toll-like receptor and matrix metalloproteinase single-nucleotide polymorphisms, haplotypes, and polygenic risk score differentiated between tuberculosis disease and infection | MENG-RUI LEE ; YEN-LIN CHEN ; Wu, Chang-Wei; LUN-CHE CHEN ; LIH-YU CHANG ; Chen, Jung-Yueh; YU-TSUNG HUANG ; JANN-YUAN WANG ; JIN-YUAN SHIH ; CHONG-JEN YU | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2 | 2 | |
2017 | Treatment delay and fatal outcomes of pulmonary tuberculosis in advanced age: A retrospective nationwide cohort study | Lee C.-H.; JANN-YUAN WANG ; Lin H.-C.; Lin P.-Y.; Chang J.-H.; Suk C.-W.; LI-NA LEE ; Lan C.-C.; Bai K.-J. | BMC Infectious Diseases | 33 | 32 | |
2021 | Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort | SHENG-KAI LIANG ; LI-TA KENG ; CHIA-HAO CHANG ; Wen, Yueh-Feng; MENG-RUI LEE ; CHING-YAO YANG ; JANN-YUAN WANG ; JEN-CHUNG KO ; JIN-YUAN SHIH ; CHONG-JEN YU | Frontiers in Oncology | 2 | 3 | |
2015 | Treatment outcome of patients with isoniazid mono-resistant tuberculosis | JUNG-YIEN CHIEN ; Chen Y.-T.; SHANG-GIN WU ; Lee J.-J.; JANN-YUAN WANG ; CHONG-JEN YU | Clinical Microbiology and Infection | 45 | 38 | |
2016 | The trend and the disease prediction of vascular endothelial growth factor and placenta growth factor in nontuberculous mycobacterial lung disease | Lin C.-H.; CHIN-CHUNG SHU ; CHIA-LIN HSU ; Cheng S.-L.; JANN-YUAN WANG ; CHONG-JEN YU ; LI-NA LEE | Scientific Reports | 6 | 5 | |
2011 | Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis | KUEI-PIN CHUNG ; Chen J.-Y.; Lee C.-H.; HUEY-DONG WU ; JANN-YUAN WANG ; LI-NA LEE ; CHONG-JEN YU ; PAN-CHYR YANG | Clinics | 50 | 44 | |
2017 | Tuberculosis contact investigation in an intermediate burden setting: Implications from a large tuberculosis contact cohort in Taiwan | MENG-RUI LEE ; CHENG-MAW HO ; Lee C.-H.; Lee M.-C.; LIH-YU CHANG ; KAI-LUN YU ; JEN-CHUNG KO ; JANN-YUAN WANG ; JANN-TAY WANG ; LI-NA LEE | European Respiratory Journal | 17 | 15 | |
2015 | Tuberculosis in healthcare workers: A matched cohort study in Taiwan | SUNG-CHING PAN ; YEE-CHUN CHEN ; JANN-YUAN WANG ; WANG-HUEI SHENG ; HSIEN-HO LIN ; CHI-TAI FANG ; SHAN-CHWEN CHANG | PLoS ONE | 13 | 12 | |
2014 | Tuberculosis mortality: Patient characteristics and causes | Lin C.-H.; Lin C.-J.; YAO-WEN KUO ; JANN-YUAN WANG ; CHIA-LIN HSU ; JONG-MIN CHEN ; WERN-CHERNG CHENG ; LI-NA LEE | BMC Infectious Diseases | 88 | 82 | |
2003 | Tuberculous myositis: A rare but existing clinical entity | JANN-YUAN WANG ; LI-NA LEE ; PO-REN HSUEH ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; PAN-CHYR YANG ; KWEN-TAY LUH | Rheumatology | 68 | 57 | |
2018 | Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan | HSIN-YUN SUN ; Huang Y.-W.; Huang W.-C.; LIH-YU CHANG ; Chan P.-C.; YU-CHUNG CHUANG ; SHENG-YUAN RUAN ; JANN-YUAN WANG ; JANN-TAY WANG | Tuberculosis | 38 | 32 | |
2010 | Unreliability of pulse contour-derived cardiac output in piglets simulating acute hemorrhagic shock and rapid volume expansion | Lee C.-H.; JANN-YUAN WANG ; Huang K.-L.; Chiu H.-W.; Fei T.-C.; Chen T.-S.; Chang H. | Journal of Trauma - Injury, Infection and Critical Care | 9 | 7 | |
2018 | Update on tuberculosis biomarkers: From correlates of risk, to correlates of active disease and of cure from disease | Goletti D.; MENG-RUI LEE ; JANN-YUAN WANG ; Walter N.; Ottenhoff T.H.M. | Respirology | 120 | 113 | |
2013 | Urinary tuberculosis is associated with the development of urothelial carcinoma but not renal cell carcinoma: A nationwide cohort study in Taiwan | Lien Y.-C.; JANN-YUAN WANG ; Lee M.-C.; CHIN-CHUNG SHU ; Chen H.-Y.; Hsieh C.-H.; Lee C.-H.; LI-NA LEE ; Chao K.-M. | British Journal of Cancer | 9 | 11 | |
2019 | Use of Antiplatelet Agents and Survival of Tuberculosis Patients: A Population-Based Cohort Study | MENG-RUI LEE ; Lee, Ming-Chia; CHIA-HAO CHANG ; CHIA-JUNG LIU ; LIH-YU CHANG ; Zhang, Jun-Fu; JANN-YUAN WANG ; Lee, Chih-Hsin | Journal of clinical medicine | 14 | 12 | |
2010 | Use of high-dose inhaled corticosteroids is associated with pulmonary tuberculosis in patients with chronic obstructive pulmonary disease | CHIN-CHUNG SHU ; HUEY-DONG WU ; Yu M.-C.; JANN-TAY WANG ; Lee C.-H.; HAO-CHIEN WANG ; JANN-YUAN WANG ; LI-NA LEE ; CHONG-JEN YU ; PAN-CHYR YANG | Medicine | 37 | 32 | |
2018 | Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection | UN-IN WU ; YU-CHUNG CHUANG ; WANG-HUEI SHENG ; HSIN-YUN SUN ; Jhong, Y. T.; JANN-YUAN WANG ; SHAN-CHWEN CHANG ; JANN-TAY WANG ; YEE-CHUN CHEN | Clinical Microbiology and Infection | 42 | 42 | |
2011 | Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease | CHIN-CHUNG SHU ; Wu M.-F.; Lee C.-H.; JANN-TAY WANG ; JANN-YUAN WANG ; CHONG-JEN YU ; LI-NA LEE ; PAN-CHYR YANG ; Su W.-J.; HSIN-CHIH LAI ; VIN-CENT WU ; Yu M.-C. | International Journal of Tuberculosis and Lung Disease | 11 | 11 | |
2022 | Whole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy | Huang, Hung Ling; Lee, Jung Yu; Lo, Yu Shu; Liu, I Hsin; Huang, Sing Han; Huang, Yu Wei; MENG-RUI LEE ; Lee, Chih Hsin; Cheng, Meng Hsuan; Lu, Po Liang; JANN-YUAN WANG ; Yang, Jinn Moon; Chong, Inn Wen | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 4 | 4 | |